Verition Fund Management
IDYA icon

Verition Fund Management’s IDEAYA Biosciences IDYA Stock Holding History

Verition Fund Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.86M Buy
+184,054
New +$5.63M 0.03% 512
2025
Q4 		– Sell
-17,290
Closed -$470K – 3699
2025
Q3 		$470K Sell
17,290
-43,597
-72% -$1.05M ﹤0.01% 3067
2025
Q2 		$1.28M Sell
60,887
-26,006
-30% -$499K 0.01% 2285
2025
Q1 		$1.42M Buy
86,893
+30,785
+55% +$656K 0.01% 1834
2024
Q4 		$1.44M Buy
56,108
+48,337
+622% +$1.37M 0.01% 1785
2024
Q3 		$246K Buy
+7,771
New +$295K ﹤0.01% 2756

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Verition Fund Management's IDYA Position: Q2 2026 in Review

Verition Fund Management opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 184,054 shares worth $6.86M. The stake represents 0.03% of the portfolio and ranks #512 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in IDYA as recently as Q3 2025.

Verition Fund Management first reported a position in IDYA in Q3 2024 and has held it in 6 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Verition Fund Management held 184,054 shares of IDEAYA Biosciences worth $6.86M as of Q2 2026.
  • IDEAYA Biosciences was a new Verition Fund Management position in Q2 2026.
  • IDEAYA Biosciences made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #512 holding.
  • Verition Fund Management first reported a position in IDEAYA Biosciences in Q3 2024 and has held it in 6 quarters since.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.